Breakthrough in Malaria detection: new FREM platform delivers 98% accuracy for rapid screening and genotyping

The Flexible, Robust, Equipment-free Microfluidic (FREM) platform for malaria screening and Plasmodium species genotyping.

Lonza unveils two separate vaccine, ADC manufacturing deals that could lead to 415 new Swiss jobs

Ahead of its Capital Markets Day on Tuesday, Lonza announced back-to-back partnership deals that cover two Swiss facility customizations and the potential creation of around

October 17, 2023

Upstream Bio raises funds to advance development of UPB-101

Upstream Bio’s UPB-101 addresses allergic and inflammatory diseases, including asthma. Credit: natatravel via Shutterstock.com. Clinical-stage biotech company Upstream Bio has raised $200m in a Series

June 9, 2023

Novo axes Phase 2 of Forma-acquired drug in myelodysplastic syndromes

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.